Addex Therapeutics Ltd

ADXN | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.53

+$0.13 (+3.98%)

At close: Sep 21, 2026, 4:00 PM ET

$3.31

-$0.22 (-6.23%)

After-hours: Sep 21, 2026, 7:45 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+3.98%

(1D)

Rating

Updated: Aug 25, 2026

31.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $4.35M

1D Range

3.34 3.57

52W Range

3.10 11.97

Valuation (TTM)

PE -0.42

PB 1.06

EV/EBITDA -0.37

Valuation (NTM)

Forward PE N/A

Forward PEG 0.02

Price Target $30

Cash Flow

FCF Yield -65.2%

SBC Adj. FCF Yield -65.8%

SBC Impact -1.0%

Margins

Gross Margin 84.3%

Operating Margin -3630.8%

FCF Margin -3143.4%

Growth (CAGR)

Revenue 3Y | 5Y -64.7% | -53.9%

Dil EPS 3Y | 5Y 110.4% | 70.0%

FCF 3Y | 5Y 59.2% | 43.8%

Returns

ROA -146.4%

ROE -131.3%

ROIC -74.4%

Financial Health

Net Cash

CHF937.5K ($1.17M)

Current Ratio 0.97

Interest Coverage -145.69

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Addex Therapeutics Ltd, a biopharmaceutical firm in a developmental phase, operates out of Switzerland, focusing on the discovery, advancement, and commercialization of small-molecule drugs targeting ...

Sector Healthcare

Industry Biotechnology

Employees 3

IPO Date Feb 11, 2020

Website www.addextherapeutics.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.